4//SEC Filing
Shaaltiel Yoseph 4
Accession 0001144204-12-026355
CIK 0001006281other
Filed
May 3, 8:00 PM ET
Accepted
May 4, 5:14 PM ET
Size
5.0 KB
Accession
0001144204-12-026355
Insider Transaction Report
Form 4
Shaaltiel Yoseph
DirectorExecutive VP, R&D
Transactions
- Sale
Common Stock
2012-05-02$7.13/sh−300,000$2,139,000→ 463,754 total
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Documents
Issuer
Protalix BioTherapeutics, Inc.
CIK 0001006281
Entity typeother
Related Parties
1- filerCIK 0001385118
Filing Metadata
- Form type
- 4
- Filed
- May 3, 8:00 PM ET
- Accepted
- May 4, 5:14 PM ET
- Size
- 5.0 KB